Dr. Lodge is the Chief Science and Innovation Officer at Cellero. She has a strong background in cell-based therapeutics and immunology, including a Ph.D. in Cell and Molecular Biology from the University of Vermont and a postdoctoral fellowship with the Multiple Sclerosis Society studying the role of T cells in the disease process. Learn more about Dr. Lodge.

Ask A Scientist:How Can Studying Antigen-Specific T Cells Help Us Make CAR T Cells More Powerful?

In the last few years, CAR T cell-based immunotherapies have shown great promise in clinical trials, and scientists are continuing to advance their knowledge with hopes of developing CAR T cell therapies for a range of cancers. CAR T cells are designed to essentially function as antigen-specific T cells, which can be difficult to collect…